Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Int J Gynecol Cancer. 2020 Mar;30(3):394-401. doi: 10.1136/ijgc-2019-001022. Epub 2020 Feb 19.
Efforts to reduce surgical morbidity related to en bloc lymph node removal associated with cancer surgery led to the development of targeted lymph node sampling to identify the lymph node(s) most likely to harbor a metastasis. Through identification of one or only a few lymph nodes at highest risk, the overall number of lymph nodes removed could be markedly reduced. Submission of fewer lymph nodes affords more detailed pathologic examination than would otherwise be practical with a standard lymph node dissection. Such enhanced pathologic examination techniques (ie, ultra-staging) have contributed to increased detection of lymph node metastases, primarily by detection of low volume metastatic disease. Based on the success of sentinel lymph node mapping and ultra-staging in breast cancer and melanoma, such techniques are increasingly used for other organ systems including the gynecologic tract. This review addresses the historical aspects of sentinel lymph node evaluation and reviews current ultra-staging protocols as well as the implications associated with increased detection of low volume metastases.
为了降低与癌症手术相关的整块淋巴结切除引起的手术发病率,人们努力开发了靶向淋巴结取样技术,以确定最有可能存在转移的淋巴结。通过识别一个或几个风险最高的淋巴结,可以显著减少切除的淋巴结总数。与标准淋巴结清扫相比,提交的淋巴结数量较少,使得病理检查更加详细。这种增强的病理检查技术(即超高分期)有助于增加淋巴结转移的检测,主要是通过检测低体积的转移性疾病。基于前哨淋巴结绘图和超高分期在乳腺癌和黑色素瘤中的成功,这些技术越来越多地用于其他器官系统,包括妇科生殖道。本文回顾了前哨淋巴结评估的历史,并回顾了当前的超高分期方案,以及与低体积转移检测增加相关的影响。